It has been shown that ACE2 is downregulated in the presence of viral infection, therefore application of recombinant ACE2 has been shown to be effective in treating severe pulmonary infections and acute respiratory distress syndrome [142]. The gene discussed is ACE2; the disease is viral infectious disease.